Product Information
NORETHIN-EE 1.5-0.03 MG(21) TB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.3556 per EA under NDC 00378727453. Its NADAC has been published 347 times since Nov 6, 2019.
Strength
.03; 1.5 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378727453
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ETHINYL ESTRADIOL; NORETHINDRONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA202770On Market Since
9/25/2019
Price Statistics
The NADAC for NORETHIN-EE 1.5-0.03 MG(21) TB has been published 347 times since Nov 6, 2019, and over the history we have for it it has declined 42.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3556 per EA |
|---|---|
| All-time high | $0.6816 (Apr 15, 2020) |
| All-time low | $0.3066 (Jul 17, 2024) |
| 52-week high | $0.4097 |
| 52-week low | $0.3344 |
| Median price | $0.5212 |
| Average price | $0.4965 |
| Largest weekly change | +67.3% (Aug 21, 2024) |
| Weeks tracked | 347 |
| Tracking since | Nov 6, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the norethindrone acetate and ethinyl estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of NORETHIN-EE 1.5-0.03 MG(21) TB?
The current National Average Drug Acquisition Cost (NADAC) for NORETHIN-EE 1.5-0.03 MG(21) TB, manufactured by Mylan Pharmaceuticals Inc., is $0.3556 per EA (NDC 00378727453), effective Jun 24, 2026.
How has the price of NORETHIN-EE 1.5-0.03 MG(21) TB changed over time?
Over the history we have for it, the NADAC for NORETHIN-EE 1.5-0.03 MG(21) TB has declined 42.4%. It has been tracked across 347 weekly CMS publications since Nov 6, 2019.
What are the highest and lowest recorded NADAC prices for NORETHIN-EE 1.5-0.03 MG(21) TB?
Since Nov 6, 2019, the NADAC for NORETHIN-EE 1.5-0.03 MG(21) TB has ranged from a low of $0.3066 (Jul 17, 2024) to a high of $0.6816 (Apr 15, 2020), with a median of $0.5212 per EA.
Are there cheaper alternatives to NORETHIN-EE 1.5-0.03 MG(21) TB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of NORETHIN-EE 1.5-0.03 MG(21) TB, so no direct lower-cost alternative is listed.
Who manufactures NORETHIN-EE 1.5-0.03 MG(21) TB?
NORETHIN-EE 1.5-0.03 MG(21) TB (NDC 00378727453) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification